abstract |
The present invention relates to a compound having the structure of formula (III):wherein the C<sub>2</sub>-<sub>4</sub> alkyl is selected from the group consisting of ethyl, isopropyl, n-propyl, butyl, and t-butyl, or an N-oxide, crystalline form, hydrate, or pharmaceutically acceptable salt thereof. |